James Walker: Unscripted

Global giant IHH Healthcare isn't just building hospitals; it's building an innovation pipeline. Its new Catalyst program aims to embed startups into its core.

Wacom's Yuify service is now on ibisPaint, offering invisible authorship protection to millions. Is this the key to winning the war on digital art theft?

Aurora Innovation and Value Truck are deploying next-gen autonomous trucks on key trade routes, aiming to ease congestion fueled by nearshoring. Is this the future?

A landmark $10B deal between NAVER, NVIDIA, and Brookfield aims to build a sovereign AI factory in South Korea, reshaping the global tech power balance.

New data reveals the hidden labor of 'Holiday Heroes.' We analyze how GetYourGuide is turning this planning pain into a strategic play for market loyalty.

Beyond the rink, the India Hockey 360 Festival is a calculated move to cultivate a new frontier. Is this the ultimate long-term investment for the sport?

The HTX Genesis Hackathon is over, but the real work has just begun. This wasn't just a contest; it's a strategic pivot to build a lasting AI x Web3 ecosystem.

The cardiac device maker swung from a loss to a stunning profit in Q2, fueled by diversification into pain management and operational excellence.

New CMS proposals threaten to dismantle remote patient monitoring as we know it, sparking a fierce debate between regulators and providers over fraud vs. access.

Fieldpoint Private's new expert team targets complex deposits, a strategic move to deepen client relationships and carve out a competitive edge in banking.

With key hires in finance, regulatory, and manufacturing, Cyllene Therapeutics signals it's preparing for the big leagues. But can it deliver?

Atmofizer Technologies is cleaning its books and funding its partner in a complex deal to bring decocainized coca extract to the public market via an RTO.

Beyond the shareholder payout, OFG Bancorp's latest dividend reflects robust financial health, savvy strategy, and the resilience of its Caribbean markets.

Vibrantz Technologies' $200M deal with Finacity isn't just a loan; it's a masterclass in using receivables to fuel global growth amid financial pressure.

A new report gives T-Mobile a perfect score, but the real story is a new benchmark for 'AI-Readiness' that redefines what makes a mobile network great.

With an oversubscribed $130M Series B, Crystalys Therapeutics is accelerating its gout drug, dotinurad. But can it win the race to serve millions?

GoldMining Inc. unveils a compelling economic case for its São Jorge gold project in Brazil, but the path from promising study to profitable mine is fraught with risk.

As Qlosi refill rates hit 49%, Orasis shuns telehealth trends, investing in programs that put eye care professionals back at the center of care.

YPulse's new MCP tool connects its 21 billion datapoints on youth culture to AI like ChatGPT, aiming to replace marketing assumptions with verifiable data.

Homeowners are sitting on trillions in equity but are locked in by low mortgage rates. Gershman Mortgage's new 5-Day HELOC offers a solution.